Targeting the Gut–Bone Axis with Prebiotics, Probiotics, Synbiotics, and Postbiotics: From Mechanistic Plausibility to Clinical Bone Outcomes
Nutrients · 2026
DOI: 10.3390/nu18182967 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Sorina Ispas und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Faculty of General Medicine, "Ovidius" University, 900470 Constanta, Romania. Hauptthemen laut MEDLINE: Prebiotics, Synbiotics, Probiotics, Bone Remodeling. Die Arbeit nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Osteoporosis is a major skeletal disorder. Increasing evidence suggests that gut microbiota-derived mechanisms may contribute to bone remodeling. The biological rationale for a gut–bone axis is well supported, but the clinical relevance of microbiome-targeted interventions remains uncertain. In this narrative review, we focus on prebiotics, probiotics, synbiotics, and postbiotics. We searched in the literature the progress from mechanistic observations to measurable skeletal outcomes in humans. We searched PubMed, Scopus, and Web of Science for literature published mainly between 2021 and 2026. We also included earlier studies when they were important for the mechanistic framework. The evidence was evaluated according to intervention type and outcome. We focused on bone turnover markers, bone mineral density, and the duration of exposure required for these outcomes to become clinically meaningful. Recent randomized trials and meta-analyses were also compared in a semi-quantitative synthesis to show where findings are consistent and where they remain conflicting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy, Faculty of General Medicine, "Ovidius" University, 900470 Constanta, Romania.
- School of Medicine, PROMISE Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medicinal Specialties, University of Palermo, 90133 Palermo, Italy.
- RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates.
- RAK College of Medical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates.
- Department of Internal Diseases Propedeutics, Yerevan State Medical University, Yerevan 0025, Armenia.
- Department and Clinic of Internal Diseases and Metabolic Disorders, Poznań University of Medical Sciences, 61-701 Poznan, Poland.
ORCID-Profile: Sorina Ispas, Viviana Maggio, Adil Farooq Wali, Sirajunisa Talath, Syed Arman Rabbani, Bhoomendra A Bhongade, Imran Rashid Rangraze, Shakta Mani Satyam, Ashot Avagimyan, Karolina Hoffmann, Ioannis Ilias, Anna Paczkowska, Mohamed El-Tanani, Manfredi Rizzo
Zitieren
APA
Ispas, S., Maggio, V., Wali, A. F., Talath, S., Rabbani, S. A., Bhongade, B. A., Rangraze, I. R., Satyam, S. M., Avagimyan, A., Hoffmann, K., Ilias, I., Paczkowska, A., El-Tanani, M., & Rizzo, M. (2026). Targeting the Gut–Bone Axis with Prebiotics, Probiotics, Synbiotics, and Postbiotics: From Mechanistic Plausibility to Clinical Bone Outcomes. Nutrients. https://doi.org/10.3390/nu18182967
Vancouver
Ispas S, Maggio V, Wali AF, Talath S, Rabbani SA, Bhongade BA, et al. Targeting the Gut–Bone Axis with Prebiotics, Probiotics, Synbiotics, and Postbiotics: From Mechanistic Plausibility to Clinical Bone Outcomes. Nutrients. 2026. doi:10.3390/nu18182967
BibTeX
@article{Ispas2026,
author = {Ispas, Sorina and Maggio, Viviana and Wali, Adil Farooq and Talath, Sirajunisa and Rabbani, Syed Arman and Bhongade, Bhoomendra A and Rangraze, Imran Rashid and Satyam, Shakta Mani and Avagimyan, Ashot and Hoffmann, Karolina and Ilias, Ioannis and Paczkowska, Anna and El-Tanani, Mohamed and Rizzo, Manfredi},
title = {Targeting the Gut–Bone Axis with Prebiotics, Probiotics, Synbiotics, and Postbiotics: From Mechanistic Plausibility to Clinical Bone Outcomes},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18182967}
}
EUVIMED